vs
百利高（PRGO）与RUSH ENTERPRISES INC \TX\（RUSHA）财务数据对比。点击上方公司名可切换其他公司
RUSH ENTERPRISES INC \TX\的季度营收约是百利高的1.5倍（$1.7B vs $1.1B），RUSH ENTERPRISES INC \TX\净利率更高（3.7% vs -127.8%，领先131.5%），百利高同比增速更快（-2.5% vs -9.0%），RUSH ENTERPRISES INC \TX\自由现金流更多（$411.6M vs $148.6M），过去两年百利高的营收复合增速更高（1.3% vs -6.8%）
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
Rush Enterprises是总部位于美国得克萨斯州新布朗费尔斯的商用车经销商，核心业务是通过旗下Rush Truck Centers销售全新及二手卡车。2019年该公司在全美20个州运营超200家卡车中心，在加拿大设有14个网点，2020年入选财富500强榜单。
PRGO vs RUSHA — 直观对比
营收规模更大
RUSHA
是对方的1.5倍
$1.1B
营收增速更快
PRGO
高出6.5%
-9.0%
净利率更高
RUSHA
高出131.5%
-127.8%
自由现金流更多
RUSHA
多$263.0M
$148.6M
两年增速更快
PRGO
近两年复合增速
-6.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.7B |
| 净利润 | $-1.4B | $61.7M |
| 毛利率 | 32.6% | 20.4% |
| 营业利润率 | -116.0% | 4.9% |
| 净利率 | -127.8% | 3.7% |
| 营收同比 | -2.5% | -9.0% |
| 净利润同比 | -3093.9% | 1.8% |
| 每股收益（稀释后） | $-10.23 | $0.77 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRGORUSHA
| Q1 26 | — | $1.7B | ||
| Q4 25 | $1.1B | $1.7B | ||
| Q3 25 | $1.0B | $1.8B | ||
| Q2 25 | $1.1B | $1.8B | ||
| Q1 25 | $1.0B | $1.8B | ||
| Q4 24 | $1.1B | $1.9B | ||
| Q3 24 | $1.1B | $1.8B | ||
| Q2 24 | $1.1B | $1.9B |
净利润PRGORUSHA
| Q1 26 | — | $61.7M | ||
| Q4 25 | $-1.4B | $64.3M | ||
| Q3 25 | $7.5M | $66.7M | ||
| Q2 25 | $-8.4M | $72.4M | ||
| Q1 25 | $-6.4M | $60.3M | ||
| Q4 24 | $-44.4M | $74.8M | ||
| Q3 24 | $-21.0M | $79.1M | ||
| Q2 24 | $-108.4M | $78.7M |
毛利率PRGORUSHA
| Q1 26 | — | 20.4% | ||
| Q4 25 | 32.6% | 20.8% | ||
| Q3 25 | 36.1% | 21.0% | ||
| Q2 25 | 34.4% | 20.7% | ||
| Q1 25 | 37.6% | 20.3% | ||
| Q4 24 | 33.9% | 19.3% | ||
| Q3 24 | 37.2% | 21.0% | ||
| Q2 24 | 37.0% | 20.2% |
营业利润率PRGORUSHA
| Q1 26 | — | 4.9% | ||
| Q4 25 | -116.0% | 5.5% | ||
| Q3 25 | 7.0% | 5.6% | ||
| Q2 25 | 4.3% | 6.0% | ||
| Q1 25 | 4.5% | 5.2% | ||
| Q4 24 | 10.0% | 5.8% | ||
| Q3 24 | 7.4% | 6.7% | ||
| Q2 24 | -2.5% | 6.4% |
净利率PRGORUSHA
| Q1 26 | — | 3.7% | ||
| Q4 25 | -127.8% | 3.8% | ||
| Q3 25 | 0.7% | 3.7% | ||
| Q2 25 | -0.8% | 3.9% | ||
| Q1 25 | -0.6% | 3.4% | ||
| Q4 24 | -3.9% | 3.9% | ||
| Q3 24 | -1.9% | 4.4% | ||
| Q2 24 | -10.2% | 4.1% |
每股收益（稀释后）PRGORUSHA
| Q1 26 | — | $0.77 | ||
| Q4 25 | $-10.23 | $0.81 | ||
| Q3 25 | $0.05 | $0.83 | ||
| Q2 25 | $-0.06 | $0.90 | ||
| Q1 25 | $-0.05 | $0.73 | ||
| Q4 24 | $-0.32 | $-95.13 | ||
| Q3 24 | $-0.15 | $0.97 | ||
| Q2 24 | $-0.79 | $97.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | $277.8M |
| 股东权益账面价值 | $2.9B | $2.3B |
| 总资产 | $8.5B | $4.5B |
| 负债/权益比越低杠杆越低 | — | 0.12× |
8季度趋势，按日历期对齐
现金及短期投资PRGORUSHA
| Q1 26 | — | — | ||
| Q4 25 | — | $212.6M | ||
| Q3 25 | $432.1M | $242.0M | ||
| Q2 25 | $454.2M | $211.1M | ||
| Q1 25 | $409.9M | $228.7M | ||
| Q4 24 | $558.8M | $228.1M | ||
| Q3 24 | $1.5B | $185.1M | ||
| Q2 24 | $542.8M | $167.3M |
总债务PRGORUSHA
| Q1 26 | — | $277.8M | ||
| Q4 25 | — | $274.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $408.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益PRGORUSHA
| Q1 26 | — | $2.3B | ||
| Q4 25 | $2.9B | $2.2B | ||
| Q3 25 | $4.4B | $2.2B | ||
| Q2 25 | $4.5B | $2.2B | ||
| Q1 25 | $4.4B | $2.2B | ||
| Q4 24 | $4.3B | $2.1B | ||
| Q3 24 | $4.6B | $2.1B | ||
| Q2 24 | $4.5B | $2.0B |
总资产PRGORUSHA
| Q1 26 | — | $4.5B | ||
| Q4 25 | $8.5B | $4.4B | ||
| Q3 25 | $10.1B | $4.6B | ||
| Q2 25 | $10.1B | $4.7B | ||
| Q1 25 | $9.8B | $4.7B | ||
| Q4 24 | $9.6B | $4.6B | ||
| Q3 24 | $11.2B | $4.6B | ||
| Q2 24 | $10.4B | $4.5B |
负债/权益比PRGORUSHA
| Q1 26 | — | 0.12× | ||
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $175.4M | — |
| 自由现金流经营现金流 - 资本支出 | $148.6M | $411.6M |
| 自由现金流率自由现金流/营收 | 13.4% | 24.4% |
| 资本支出强度资本支出/营收 | 2.4% | 2.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $145.1M | $828.4M |
8季度趋势，按日历期对齐
经营现金流PRGORUSHA
| Q1 26 | — | — | ||
| Q4 25 | $175.4M | $112.9M | ||
| Q3 25 | $51.7M | $367.8M | ||
| Q2 25 | $75.9M | $227.6M | ||
| Q1 25 | $-64.5M | $153.5M | ||
| Q4 24 | $312.6M | $392.3M | ||
| Q3 24 | $42.2M | $111.7M | ||
| Q2 24 | $9.5M | $270.6M |
自由现金流PRGORUSHA
| Q1 26 | — | $411.6M | ||
| Q4 25 | $148.6M | $31.9M | ||
| Q3 25 | $29.8M | $271.2M | ||
| Q2 25 | $56.7M | $113.8M | ||
| Q1 25 | $-90.0M | $45.1M | ||
| Q4 24 | $274.9M | $263.5M | ||
| Q3 24 | $15.1M | $-20.0M | ||
| Q2 24 | $-18.9M | $177.2M |
自由现金流率PRGORUSHA
| Q1 26 | — | 24.4% | ||
| Q4 25 | 13.4% | 1.9% | ||
| Q3 25 | 2.9% | 15.2% | ||
| Q2 25 | 5.4% | 6.2% | ||
| Q1 25 | -8.6% | 2.6% | ||
| Q4 24 | 24.2% | 13.7% | ||
| Q3 24 | 1.4% | -1.1% | ||
| Q2 24 | -1.8% | 9.1% |
资本支出强度PRGORUSHA
| Q1 26 | — | 2.0% | ||
| Q4 25 | 2.4% | 4.8% | ||
| Q3 25 | 2.1% | 5.4% | ||
| Q2 25 | 1.8% | 6.2% | ||
| Q1 25 | 2.4% | 6.2% | ||
| Q4 24 | 3.3% | 6.7% | ||
| Q3 24 | 2.5% | 7.3% | ||
| Q2 24 | 2.7% | 4.8% |
现金转化率PRGORUSHA
| Q1 26 | — | — | ||
| Q4 25 | — | 1.75× | ||
| Q3 25 | 6.89× | 5.51× | ||
| Q2 25 | — | 3.14× | ||
| Q1 25 | — | 2.55× | ||
| Q4 24 | — | 5.25× | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 3.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
RUSHA
| New and used commercial vehicle sales | $955.1M | 57% |
| Aftermarket products and services sales | $627.2M | 37% |
| Lease and rental sales | $92.3M | 5% |
| Finance and insurance | $5.6M | 0% |
